相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endoplasmic Reticulum Dysfunction in Alzheimer's Disease
Jie-Qiong Li et al.
MOLECULAR NEUROBIOLOGY (2015)
Endoplasmic reticulum stress as a novel neuronal mediator in Alzheimer's disease
Han-Chang Huang et al.
NEUROLOGICAL RESEARCH (2015)
Body Mass Index, Weight Change, and Clinical Progression in Mild Cognitive Impairment and Alzheimer Disease
Lilah M. Besser et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2014)
Value of Serum Nonceruloplasmin Copper for Prediction of Mild Cognitive Impairment Conversion to Alzheimer Disease
Rosanna Squitti et al.
ANNALS OF NEUROLOGY (2014)
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
D. Allan Butterfield et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Feelings Without Memory in Alzheimer Disease
Edmarie Guzman-Velez et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2014)
Non-chaperone Proteins Can Inhibit Aggregation and Cytotoxicity of Alzheimer Amyloid β Peptide
Jinghui Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Amyloid-β Peptide-specific DARPins as a Novel Class of Potential Therapeutics for Alzheimer Disease
Michael Hanenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death
Lishu Duan et al.
MOLECULAR NEURODEGENERATION (2014)
High serum levels of the pesticide metabolite DDE—a potential environmental risk factor for Alzheimer disease
Ellen Bible
Nature Reviews Neurology (2014)
The Mini Mental State Examination at the Time of Alzheimer's Disease and Related Disorders Diagnosis, According to Age, Education, Gender and Place of Residence: A Cross-Sectional Study among the French National Alzheimer Database
Christian Pradier et al.
PLOS ONE (2014)
Environmental factors in the development and progression of late-onset Alzheimer's disease
Moses N. Wainaina et al.
NEUROSCIENCE BULLETIN (2014)
Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy
Shuko Takeda et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Elevated Serum DDE and Risk for Alzheimer Disease
Alfred Bernard
JAMA NEUROLOGY (2014)
Elevated Serum Pesticide Levels and Risk for Alzheimer Disease
Jason R. Richardson et al.
JAMA NEUROLOGY (2014)
Synthesis of a Targeted Library of Heparan Sulfate Hexa- to Dodecasaccharides as Inhibitors of β-Secretase: Potential Therapeutics for Alzheimer's Disease
Ralf Schwoerer et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Role of the Transforming-Growth-Factor-β1 Gene in Late-Onset Alzheimer's Disease: Implications for the Treatment
Paolo Bosco et al.
CURRENT GENOMICS (2013)
Calreticulin Regulates Transforming Growth Factor-β-stimulated Extracellular Matrix Production
Kurt A. Zimmerman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Examination of the Clinicopathologic Continuum of Alzheimer Disease in the Autopsy Cohort of the National Alzheimer Coordinating Center
Alberto Serrano-Pozo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Effects of the APOE ε4 allele on brain development
Hemi Malkki
Nature Reviews Neurology (2013)
Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions
Christine M. Burns et al.
NEUROLOGY (2013)
Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice
A. Trueba-Saiz et al.
TRANSLATIONAL PSYCHIATRY (2013)
Reduced Calreticulin Levels Link Endoplasmic Reticulum Stress and Fas-Triggered Cell Death in Motoneurons Vulnerable to ALS
Nathalie Bernard-Marissal et al.
JOURNAL OF NEUROSCIENCE (2012)
Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease
Ming-Hui Yang et al.
JOURNAL OF PROTEOMICS (2012)
High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population
Afef Achouri Rassas et al.
NEUROLOGICAL SCIENCES (2012)
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease
M. Watabe-Rudolph et al.
NEUROLOGY (2012)
Epidemiology of Alzheimer Disease
Richard Mayeux et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Calorie Restriction and Aging in Nonhuman Primates
Joseph W. Kemnitz
ILAR JOURNAL (2011)
Calreticulin is crucial for calcium homeostasis mediated adaptation and survival of thick ascending limb of Henle's loop cells under osmotic stress
Asima Bibi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
T1ρ MRI in Alzheimer's Disease: Detection of Pathological Changes in Medial Temporal Lobe
Mohammad Haris et al.
JOURNAL OF NEUROIMAGING (2011)
Alzheimer disease biomarkers are associated with body mass index
E. D. Vidoni et al.
NEUROLOGY (2011)
Calreticulin chaperones regulate functional expression of vomeronasal type 2 pheromone receptors
Sandeepa Dey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Detection of Elevated Antibody against Calreticulin by ELISA in Aged Cynomolgus Monkey Plasma
Atsunori Higashino et al.
ZOOLOGICAL SCIENCE (2011)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective Disorders
Abraham Reichenberg et al.
SCHIZOPHRENIA BULLETIN (2009)
Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease
Osvaldo P. Almeida et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Alzheimer Disease and Cognitive Reserve Variation of Education Effect With Carbon 11-Labeled Pittsburgh Compound B Uptake
Catherine M. Roe et al.
ARCHIVES OF NEUROLOGY (2008)
A polymorphism in CALHM1 influences Ca2+ homeostasis, Aβ levels, and Alzheimer's disease risk
Ute Dreses-Werringloer et al.
CELL (2008)
Interaction of Calreticulin with Amyloid Beta Peptide 1-42
G. Houen et al.
PROTEIN AND PEPTIDE LETTERS (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease
Valeska Marinho et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Delineation of the lectin site of the molecular chaperone calreticulin
SP Thomson et al.
CELL STRESS & CHAPERONES (2005)
Differential immune cell chemotaxis responses to acute psychological stress in Alzheimer caregivers compared to non-caregiver controls
L Redwine et al.
PSYCHOSOMATIC MEDICINE (2004)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease
M Kivipelto et al.
ANNALS OF INTERNAL MEDICINE (2002)
Lipoproteinoxidation as a common pathomechanism in coronary heart disease and Alzheimer's disease
S Arlt et al.
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE (2001)
Possible consequences of social drinking in the early stages of Alzheimer disease
R Wiscott et al.
GERIATRIC NURSING (2001)
Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain
J Taguchi et al.
ACTA NEUROPATHOLOGICA (2000)
分享论文
